Skip to content

Impact of Perioperative Organ Resuscitation of Brain-dead Deceased Organ Donor on Kidney Graft Function in the Recipient

Impact of Perioperative Organ Resuscitation of Brain-dead Deceased Organ Donor on Kidney Graft Function in the Recipient

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06907758
Acronym
OPTI-PMO 2
Enrollment
50
Registered
2025-04-02
Start date
2024-04-10
Completion date
2025-12-10
Last updated
2025-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Graft

Keywords

Kidney Graft, Grafts, Organ transplantation

Brief summary

Brain-dead patients are the primary source of grafts for those awaiting organ transplantation. Recommendations exist for the management of these potential donors, based on the concept of organ resuscitation, according to which targeted resuscitation would improve graft quality and quantity. Graft performance thus depends on fixed factors (donor/recipient age, medical history, etc.) but also potentially modifiable factors. Through this study, the investigators aim to identify potentially modifiable factors in our donor care (in intensive care and the operating room) that may influence graft function in the recipient. For simplicity, the investigators will focus on kidney grafts. The aim is to improve the effectiveness of the transplant and reduce waiting times.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

The inclusion criteria for organ donor patients are as follows: * Adult patient * Brain dead * Hospitalized in surgical intensive care at Strasbourg University Hospital (NHC cardiovascular intensive care unit, NHC multi-purpose intensive care unit, Hautepierre surgical intensive care unit) from January 1, 2018 to December 31, 2023 * Having undergone multi-organ transplantation * At least one of the donor kidneys has been transplanted to a patient at Strasbourg University Hospital * Absence of written objection in the medical file of the subject (and/or their legal representative, if applicable) to the reuse of their data for scientific research purposes. The inclusion criteria for kidney transplant recipients are as follows: * Adult patient * Recipient of a kidney transplant from an organ donor who meets the inclusion criteria for donor patients mentioned above * Patient who has undergone surgery and is hospitalized post-operatively at Strasbourg University Hospital * Patient monitored by the Strasbourg University Hospital transplant team * Absence of written objection in the subject's medical file (and/or their legal representative, if applicable) to the reuse of their data for scientific research purposes.

Exclusion criteria

* Subject (and/or their legal representative, if applicable) who has expressed their opposition to the reuse of their data for scientific research purposes * Brain-dead patient who has not undergone organ retrieval * Brain-dead patient whose kidney has not been allocated to a recipient in Strasbourg * Patient transferred to the Strasbourg University Hospital's intensive care unit from another hospital in a state of already diagnosed brain death solely for organ retrieval * Kidney transplant patient with a graft from a living donor * Kidney transplant patient with a graft from a deceased donor who is not brain-dead * Kidney transplant patient with a graft from a deceased donor who is brain-dead and hospitalized in a hospital other than Strasbourg

Design outcomes

Primary

MeasureTime frameDescription
Ratio of creatinine decreaseDays 1 and 2 in kidney transplant recipientsRatio of creatinine decrease on days 1 and 2 in kidney transplant recipients (formula: CRR2% = ((Cr1-Cr2)\*100)/Cr1) or the need for dialysis before day 2.

Countries

France

Contacts

Primary ContactCharlotte POUSSARDIN, MD
charlotte.poussardin@chru-strasbourg.fr33.3.69.55.16.21

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026